Business
CLO Sells LGND 5,000 Shares for $1.0 Million
March 31, 2026
The Motley Fool
Scroll
Ligand Pharmaceuticals, a leader in drug licensing and royalties, reported a notable insider sale amid strong recent share performance.
The Motley Fool
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left